Mandate

Vinge Advises PSI on Cross-Border Merger

April 24, 2008

The Board of Directors in CashGuard AB (publ), listed on the OMX Nordic Exchange Stockholm, and the PSI Group ASA, listed on the Oslo Exchange, has entered into an agreement to implement a cross-border merger. The largest shareholders in both companies support the merger, which is proposed to be implemented with PSI as the acquiring company. On the international technology market the merger between PSI and CashGuard will form a leading company. 
 
The new company will have its primary listing in Norway but will apply for a secondary listing in Sweden. The merger must be approved by both companies' general meetings, which are estimated to be held in early June 2008, and the approval of relevant competition authorities.

Vinge’s team included Johan Cederlund, Pontus Enquist and Lennart Larsson, among others. 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026